EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+13.49%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.37B
AUM Growth
+$167M
(+14%)
Cap. Flow
+$25.9M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
57.21%
Holding
359
New
25
Increased
120
Reduced
185
Closed
27
Top Buys
| 1 |
Microsoft
MSFT
|
$22.3M |
| 2 |
Pinduoduo
PDD
|
$13.5M |
| 3 |
NIO
NIO
|
$13.1M |
| 4 |
Marvell Technology
MRVL
|
$11.4M |
| 5 |
TSMC
TSM
|
$10.4M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$24.2M |
| 2 |
Legend Biotech
LEGN
|
$19.1M |
| 3 |
Trip.com Group
TCOM
|
$15.6M |
| 4 |
Zai Lab
ZLAB
|
$7.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$3.55M |
Sector Composition
| 1 | Consumer Discretionary | 36.1% |
| 2 | Technology | 29.22% |
| 3 | Communication Services | 14% |
| 4 | Healthcare | 8.72% |
| 5 | Real Estate | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
226
DELISTED
Immunogen Inc
IMGN
| $298K | 0.02% |
77,663
+5,958
| +8% | +$22.9K |
|
227
Rambus
RMBS
$8.05B
| $296K | 0.02% |
+5,775
| New | +$296K |
|
|
BLUE
228
DELISTED
bluebird bio
BLUE
| $293K | 0.02% |
4,607
+1,785
| +63% | +$114K |
|
229
Rocket Pharmaceuticals
RCKT
$354M
| $291K | 0.02% |
17,001
+1,601
| +10% | +$27.4K |
|
|
CERE
230
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $291K | 0.02% |
11,932
-577
| -5% | -$14.1K |
|
231
Corning
GLW
$61B
| $290K | 0.02% |
8,215
+577
| +8% | +$20.4K |
|
232
Immunovant
IMVT
$2.99B
| $289K | 0.02% |
18,623
+6,824
| +58% | +$106K |
|
233
CDW
CDW
$22.2B
| $285K | 0.02% |
1,462
+105
| +8% | +$20.5K |
|
234
NextEra Energy, Inc.
NEE
$146B
| $285K | 0.02% |
3,702
-145
| -4% | -$11.2K |
|
235
Stryker
SYK
$150B
| $284K | 0.02% |
994
-92
| -8% | -$26.3K |
|
236
Editas Medicine
EDIT
$248M
| $282K | 0.02% |
38,855
-1,525
| -4% | -$11.1K |
|
237
Philip Morris
PM
$251B
| $281K | 0.02% |
2,888
-113
| -4% | -$11K |
|
238
Krystal Biotech
KRYS
$4.35B
| $279K | 0.02% |
3,488
+260
| +8% | +$20.8K |
|
239
Credo Technology Group
CRDO
$24.4B
| $278K | 0.02% |
+29,479
| New | +$278K |
|
240
Gartner
IT
$18.6B
| $278K | 0.02% |
854
+60
| +8% | +$19.5K |
|
241
Constellation Energy
CEG
$94.2B
| $277K | 0.02% |
3,524
-231
| -6% | -$18.2K |
|
242
Royal Caribbean
RCL
$95.7B
| $277K | 0.02% |
4,244
-4,893
| -54% | -$319K |
|
243
Biohaven
BHVN
$1.68B
| $276K | 0.02% |
20,233
+1,759
| +10% | +$24K |
|
244
89bio
ETNB
$1.32B
| $276K | 0.02% |
+18,140
| New | +$276K |
|
245
HP
HPQ
$27.4B
| $274K | 0.02% |
9,327
+468
| +5% | +$13.7K |
|
|
CTIC
246
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $271K | 0.02% |
64,520
-12,581
| -16% | -$52.8K |
|
247
CVS Health
CVS
$93.6B
| $270K | 0.02% |
3,639
+60
| +2% | +$4.45K |
|
248
Agios Pharmaceuticals
AGIO
$2.09B
| $269K | 0.02% |
11,701
+605
| +5% | +$13.9K |
|
249
Avidity Biosciences
RNA
$6.48B
| $269K | 0.02% |
17,521
+5,075
| +41% | +$77.9K |
|
250
Diamondback Energy
FANG
$40.2B
| $268K | 0.02% |
1,979
-26
| -1% | -$3.52K |
|